Extract from the Register of European Patents

EP About this file: EP0099770

EP0099770 - Oxazinobenzothiazine-6,6-dioxide derivatives, their preparation and their use as medicament [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.06.1987
Database last updated on 09.04.2026
Most recent event   Tooltip12.05.1990Lapse of the patent in a contracting statepublished on 27.06.1990 [1990/26]
Applicant(s)For all designated states
PROVESAN S.A.
1, place St Gervais
1211 Genève / CH
[N/P]
Former [1984/05]For all designated states
PROVESAN S.A.
1, place St Gervais
CH-1211 Genève / CH
Inventor(s)01 / Esteve Soler, José
Via Augusta 244
Barcelone / ES
[1984/05]
Representative(s)Ahner, Francis, et al
Cabinet Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
[N/P]
Former [1984/05]Ahner, Francis, et al
CABINET REGIMBEAU 26, avenue Kléber
F-75116 Paris / FR
Application number, filing date83401168.608.06.1983
[1984/05]
Priority number, dateFR1982001040915.06.1982         Original published format: FR 8210409
[1984/05]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report 
No.:EP0099770
Date:01.02.1984
Language:FR
[1984/05]
Type: B1 Patent specification 
No.:EP0099770
Date:27.08.1986
Language:FR
[1986/35]
Search report(s)(Supplementary) European search report - dispatched on:EP15.11.1983
ClassificationIPC:C07D513/04, A61K31/54, // (C07D513/04, 279:00, 265:00)
[1984/05]
CPC:
C07D513/04 (EP,US); A61P25/04 (EP); A61P29/00 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1984/05]
TitleGerman:Oxazinobenzothiazin-6,6-dioxidederivate, ihre Herstellung und Anwendung als Arzneimittel[1984/05]
English:Oxazinobenzothiazine-6,6-dioxide derivatives, their preparation and their use as medicament[1984/05]
French:Nouveaux dérivés d'oxazinobenzothiazine-6,6-dioxyde, leur préparation et leur application en tant que médicaments[1984/05]
Examination procedure09.07.1984Examination requested  [1984/37]
19.06.1985Despatch of a communication from the examining division (Time limit: M04)
08.07.1985Reply to a communication from the examining division
23.01.1986Despatch of communication of intention to grant (Approval: )
24.02.1986Communication of intention to grant the patent
05.05.1986Fee for grant paid
05.05.1986Fee for publishing/printing paid
Opposition(s)28.05.1987No opposition filed within time limit [1987/33]
Fees paidRenewal fee
15.05.1985Renewal fee patent year 03
20.05.1986Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]   JOURNAL OF MEDICINAL CHEMISTRY, vol. 16, no. 1, 1er janvier 1973, pages 44-48, Columbus, Ohio, USA
Examination  JOURNAL OF MEDICINAL CHEMISTRY, vol. 16, no. 1, 1er janvier 1973, pages 44-48, Columbus, Ohio, USA, H. ZINNES et al.: "1,2-benzothiazines. 6. 3-carbamoyl-4-hydroxy-2H-1,2-benzothiazine 1,1-dioxides as antiinflammatory agents"
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.